Continue reading this on our app for a better experience

Open in App
Floating Button
Home Capital Broker's Calls

Maybank keeps 'buy' call and $1.65 target price on Raffles Medical following Vietnam and Changi deals

The Edge Singapore
The Edge Singapore • 2 min read
Maybank keeps 'buy' call and $1.65 target price on Raffles Medical following Vietnam and Changi deals
Photo: The Edge Singapore
Font Resizer
Share to Whatsapp
Share to Facebook
Share to LinkedIn
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

Maybank Securities' Eric Ong has kept his "buy" call and $1.65 target price on Raffles Medical Group BSL

, following its latest move to acquire an undisclosed majority stake in a hospital in Vietnam.

The 120-bed American International Hospital in Ho Chi Minh City has been valued at US$45.6 million. Upon completion of the deal, Raffles Medical will be managing this hospital too.

According to Raffles Medical, AIH has seen steady growth in both outpatient and inpatient volumes since inception. "That said, we do not expect any near-term contribution from this proposed acquisition, which may take at least 6-9 months to complete, subject to the fulfilment of certain conditions and relevant approvals," says Ong.

Nonetheless, the deal will enable Raffles Medical to ride on growing demand for private healthcare services in Vietnam and augment its clinic operations there.

"Leveraging on its strong balance sheet, we believe this is an integral part of Raffles Medical's long-term strategy to expand its income stream, while diversifying the group’s hospital operations beyond Singapore and China," says Ong.

Separately, Raffles Medical has extended its contract to provide medical services at Connect@Changi until Feb 2025. 

See also: Test debug host entity

According to Ong, the contract at Conenct@Changi was won at $151,392 per month, which was 54% lower than the next closest bidder. 

Ong believes Raffles Medical is able to put in such a lower bid because it has already sunk in one-off set-up costs.

"Nevertheless, we expect margins to normalise given the higher opex of running the facility," says Ong, whose $1.65 target price is based on a discounted cash flow valuation model.

See also: Maybank downgrades ComfortDelGro in contrarian call over Addison Lee acquisition worries

Raffles Medical shares traded at $1.24 as at 3.37pm, up 0.81%.

 

Highlights

Re test Testing QA Spotlight
1000th issue

Re test Testing QA Spotlight

Get the latest news updates in your mailbox
Never miss out on important financial news and get daily updates today
×
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
© 2024 The Edge Publishing Pte Ltd. All rights reserved.